Montair
Intended to relieve allergic bronchoconstriction to support easy respiration and target seasonal allergen sensitivity.
- Category
- Allergy Relief
- Active ingredient
- Montelukast
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg
Prescription and consultation requirements for Montair vary by destination and are determined by the fulfilment partner.
Montair details
- Alternative names
- montelukast
- Therapeutic class
- Leukotriene Receptor Antagonist
- Pharmacological class
- Antiasthmatic/Antiallergic
- Contraindications
- severe hypersensitivity to montelukast
- Minor side effects
- headache; nausea; cough
- Moderate side effects
- sinusitis; abdominal pain; fatigue
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Phenobarbital; Rifampin
- Age restrictions
- Approved for paediatric and adult populations.
Serious side effects
neuropsychiatric events, requires immediate medical attention; systemic eosinophilia, requires immediate medical attention
Patient summary
intended to relieve allergic bronchoconstriction to support easy respiration and target seasonal allergen sensitivity.
Mechanism of action
Selectively blocks cysteinyl leukotriene receptors, resolving local airway hyperreactivity and mucosal oedema.
Pregnancy and breastfeeding
TGA Category B: Safety established in clinical trials. Breastfeeding: Compatible.